Sign in
8-K

Current Report

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-026946

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing